Home › Companies › KRYSTAL BIOTECH INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and KRYSTAL BIOTECH INC.’s Form 8-K, filed May 21, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 17, 2024: 5 items on KRYSTAL BIOTECH INC.’s Form 8-K, filed May 21, 2024: 2 approved · 3 passed (calculated).
Significant dissent: 1 director (23.6% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore KRYSTAL BIOTECH INC. in the interactive database Compare manager voting policies
These tallies are KRYSTAL BIOTECH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Suma M. Krishnan | 21,058,004 | -- | -- | 1,498,017 | 2,244,047 | 93% | Passed (calculated) | — |
| Elect Director: Julian S. Gangolli | 17,226,067 | -- | -- | 5,329,954 | 2,244,047 | 76% | Passed (calculated) | — |
| Elect Director: Catherine Mazzacco | 20,382,924 | -- | -- | 2,173,097 | 2,244,047 | 90% | Passed (calculated) | — |
| 2. Ratification of Appointment of Independent Registered Public Accounting Firm | 24,769,838 | 7,438 | 22,792 | -- | -- | 99.9% | Approved | — |
| 3. Non-Binding, Advisory Vote on Named Executive Officer Compensation | 21,697,311 | 851,690 | 7,020 | -- | 2,244,047 | 96% | Approved | — |
This meeting is also recorded here as May 21, 2024; both records come from the same filing, so the date should be checked against it.
Source: KRYSTAL BIOTECH INC., Form 8-K, filed with the SEC on May 21, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
256 asset managers disclosed a vote on at least one KRYSTAL BIOTECH INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Catherine Mazzacco
KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Catherine Mazzacco”): 20,382,924 for, 2,173,097 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 85 asset managers below reported 9,625,171 for, 14 against, 958,894 withheld, 95,219 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,613,988 | 0 | 0 | 0 | For |
| Vanguard | 2,370,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 531,854 | 0 | 0 | 0 | For |
| BlackRock | 496,028 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 468,691 | Withhold |
| State Street | 462,085 | 0 | 0 | 626 | For |
| Lord Abbett | 347,342 | 0 | 0 | 0 | For |
| Prudential/PGIM | 342,273 | 0 | 0 | 2,414 | For |
| Manager Directed Portfolios | 246,194 | 0 | 0 | 0 | For |
| TIAA | 242,516 | 0 | 0 | 0 | For |
| Charles Schwab | 188,778 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 136,485 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 88,375 | Withhold |
| TimesSquare Capital Management, LLC | 84,841 | 0 | 0 | 0 | For |
| Equitable | 47,770 | 0 | 0 | 23,260 | Mixed |
| Goldman Sachs | 0 | 0 | 0 | 67,089 | Withhold |
| Franklin Custodian Funds | 60,000 | 0 | 0 | 0 | For |
| Nuveen | 56,523 | 0 | 0 | 0 | For |
| Putnam | 51,045 | 0 | 0 | 0 | For |
| John Hancock | 36,281 | 0 | 8,033 | 0 | Mixed |
| Columbia Threadneedle | 43,692 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,934 | 0 | 39,120 | 0 | Mixed |
| Jackson National | 0 | 0 | 40,316 | 0 | Abstain |
| Allspring | 0 | 0 | 0 | 39,102 | Withhold |
| Aberdeen | 0 | 0 | 0 | 39,024 | Withhold |
Showing the 25 largest of 85 asset managers. All 85 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Julian S. Gangolli
KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Julian S. Gangolli”): 17,226,067 for, 5,329,954 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 85 asset managers below reported 8,907,811 for, 14 against, 1,651,657 withheld, 119,816 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,613,988 | 0 | 0 | 0 | For |
| Vanguard | 2,370,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 531,854 | 0 | 0 | 0 | For |
| BlackRock | 496,028 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 468,691 | Withhold |
| State Street | 460 | 0 | 0 | 462,251 | Withhold |
| Lord Abbett | 347,342 | 0 | 0 | 0 | For |
| Prudential/PGIM | 342,273 | 0 | 0 | 2,414 | For |
| Manager Directed Portfolios | 246,194 | 0 | 0 | 0 | For |
| TIAA | 242,516 | 0 | 0 | 0 | For |
| Charles Schwab | 188,778 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 136,485 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 88,375 | Withhold |
| TimesSquare Capital Management, LLC | 84,841 | 0 | 0 | 0 | For |
| Equitable | 47,770 | 0 | 0 | 23,260 | Mixed |
| Goldman Sachs | 0 | 0 | 0 | 67,089 | Withhold |
| Franklin Custodian Funds | 0 | 0 | 0 | 60,000 | Withhold |
| Nuveen | 56,523 | 0 | 0 | 0 | For |
| Putnam | 51,045 | 0 | 0 | 0 | For |
| John Hancock | 36,281 | 0 | 8,033 | 0 | Mixed |
| Columbia Threadneedle | 0 | 0 | 0 | 43,692 | Withhold |
| Bridge Builder Trust | 3,934 | 0 | 39,120 | 0 | Mixed |
| Jackson National | 0 | 0 | 40,316 | 0 | Abstain |
| Allspring | 0 | 0 | 0 | 39,102 | Withhold |
| Aberdeen | 0 | 0 | 0 | 39,024 | Withhold |
Showing the 25 largest of 85 asset managers. All 85 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Suma M. Krishnan
KRYSTAL BIOTECH INC.’s own tally for this item (“Elect Director: Suma M. Krishnan”): 21,058,004 for, 1,498,017 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 85 asset managers below reported 9,690,504 for, 980,014 withheld, 8,780 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,613,988 | 0 | 0 | 0 | For |
| Vanguard | 2,370,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 531,854 | 0 | 0 | 0 | For |
| BlackRock | 496,028 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 468,691 | Withhold |
| State Street | 1,033 | 0 | 0 | 461,678 | Withhold |
| Lord Abbett | 347,342 | 0 | 0 | 0 | For |
| Prudential/PGIM | 344,687 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 246,194 | 0 | 0 | 0 | For |
| TIAA | 242,516 | 0 | 0 | 0 | For |
| Charles Schwab | 188,778 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 136,485 | 0 | 0 | 0 | For |
| Victory Capital | 88,375 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 84,841 | 0 | 0 | 0 | For |
| Equitable | 47,770 | 0 | 0 | 23,260 | Mixed |
| Goldman Sachs | 67,089 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 60,000 | 0 | 0 | 0 | For |
| Nuveen | 56,523 | 0 | 0 | 0 | For |
| Putnam | 51,045 | 0 | 0 | 0 | For |
| John Hancock | 44,314 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 43,692 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 43,054 | 0 | 0 | 0 | For |
| Jackson National | 34,141 | 0 | 6,175 | 0 | Mixed |
| Allspring | 39,102 | 0 | 0 | 0 | For |
| Aberdeen | 39,024 | 0 | 0 | 0 | For |
Showing the 25 largest of 85 asset managers. All 85 are in the interactive database (link above).
Combines 16 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING, ADVISORY BASIS.
KRYSTAL BIOTECH INC.’s own tally for this item (“3. Non-Binding, Advisory Vote on Named Executive Officer Compensation”): 21,697,311 for, 851,690 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Three: Non-Binding, Advisory Vote on Named Executive Officer Compensation The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers for the fiscal year ended December 31, 2023, as disclosed in the Company's proxy sta…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,613,988 | 0 | 0 | 0 | For |
| Vanguard | 2,370,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 531,854 | 0 | 0 | 0 | For |
| BlackRock | 496,028 | 0 | 0 | 0 | For |
| Dimensional | 468,691 | 0 | 0 | 0 | For |
| State Street | 462,711 | 0 | 0 | 0 | For |
| Lord Abbett | 347,342 | 0 | 0 | 0 | For |
| Prudential/PGIM | 344,687 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 246,194 | 0 | 0 | 0 | For |
| TIAA | 242,516 | 0 | 0 | 0 | For |
| Charles Schwab | 188,778 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 136,485 | 0 | 0 | 0 | For |
| Victory Capital | 88,375 | 0 | 0 | 0 | For |
| Equitable | 71,030 | 0 | 0 | 0 | For |
| Goldman Sachs | 67,089 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 60,000 | 0 | 0 | 0 | For |
| Nuveen | 56,523 | 0 | 0 | 0 | For |
| Putnam | 51,045 | 0 | 0 | 0 | For |
| John Hancock | 44,314 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 43,692 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 43,054 | 0 | 0 | 0 | For |
| Jackson National | 40,316 | 0 | 0 | 0 | For |
| Allspring | 39,102 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 39,024 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 38,159 | 0 | 0 | 0 | For |
Fund voting reports, all 84 managers: 10,537,576 for, 39,634 against, 2,820 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,243,326 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 1,508,250 | 0 | 0 | 0 | For |
| State Street | 886,159 | 0 | 0 | 0 | For |
| T. Rowe Price | 655,737 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 587,696 | 1,364 | 0 | 0 | For |
| BlackRock | 539,055 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 497,283 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 463,142 | 0 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 425,363 | 0 | 0 | 0 | For |
| Nuveen | 324,578 | 0 | 0 | 0 | For |
| UBS | 0 | 265,652 | 0 | 0 | Against |
| Woodline Partners LP | 252,526 | 0 | 0 | 0 | For |
| SEB Investment Management AB | 0 | 244,061 | 0 | 0 | Against |
| Charles Schwab | 188,800 | 0 | 0 | 0 | For |
| Northern Trust | 180,912 | 15 | 0 | 0 | For |
| JPMorgan | 168,698 | 0 | 0 | 0 | For |
| Victory Capital | 158,022 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 157,550 | 0 | 0 | Against |
| C WorldWide Asset Management Fondsmaeglerselskab A/S | 0 | 135,809 | 0 | 0 | Against |
| PICTET ASSET MANAGEMENT SA | 111,098 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 100,773 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 90,400 | 0 | 0 | 0 | For |
| S Squared Technology, LLC | 90,215 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 85,979 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 84,841 | 0 | 0 | 0 | For |
Institutional-manager reports, all 194 managers: 13,135,435 for, 960,407 against, 326 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2024.
KRYSTAL BIOTECH INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm”): 24,769,838 for, 7,438 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 10,680,571 for, 81 against, 2,820 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,613,988 | 0 | 0 | 0 | For |
| Vanguard | 2,370,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 531,854 | 0 | 0 | 0 | For |
| BlackRock | 496,028 | 0 | 0 | 0 | For |
| Dimensional | 468,691 | 0 | 0 | 0 | For |
| State Street | 462,711 | 0 | 0 | 0 | For |
| Lord Abbett | 347,342 | 0 | 0 | 0 | For |
| Prudential/PGIM | 344,687 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 246,194 | 0 | 0 | 0 | For |
| TIAA | 242,516 | 0 | 0 | 0 | For |
| Charles Schwab | 188,778 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 136,485 | 0 | 0 | 0 | For |
| Victory Capital | 88,375 | 0 | 0 | 0 | For |
| TimesSquare Capital Management, LLC | 84,841 | 0 | 0 | 0 | For |
| Equitable | 71,030 | 0 | 0 | 0 | For |
| Goldman Sachs | 67,089 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 60,000 | 0 | 0 | 0 | For |
| Nuveen | 56,523 | 0 | 0 | 0 | For |
| Putnam | 51,045 | 0 | 0 | 0 | For |
| John Hancock | 44,314 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 43,692 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 43,054 | 0 | 0 | 0 | For |
| Jackson National | 40,316 | 0 | 0 | 0 | For |
| Allspring | 39,102 | 0 | 0 | 0 | For |
| Aberdeen | 39,024 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 28,528,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 12.67% |
| 2 | Vanguard | 8.31% |
| 3 | T. Rowe Price | 1.86% |
| 4 | BlackRock | 1.74% |
| 5 | Dimensional | 1.64% |
| 6 | State Street | 1.62% |
| 7 | Lord Abbett | 1.22% |
| 8 | Prudential/PGIM | 1.21% |
| 9 | Manager Directed Portfolios | 0.86% |
| 10 | TIAA | 0.85% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.87% |
| 2 | Redmile Group, LLC | 5.29% |
| 3 | State Street | 3.11% |
| 4 | T. Rowe Price | 2.30% |
| 5 | JENNISON ASSOCIATES LLC | 2.06% |
| 6 | BlackRock | 1.89% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.74% |
| 8 | Hood River Capital Management LLC | 1.62% |
| 9 | LORD, ABBETT & CO. LLC | 1.49% |
| 10 | Nuveen | 1.14% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| FMR (Fidelity) | 4,341,447 | 15.22% | Form 13F, quarter ended March 31, 2024 |
| BlackRock | 3,834,128 | 13.44% | Form 13F, quarter ended March 31, 2024 |
| FMR LLC | 3,349,474 | 11.74% | Proxy statement (DEF 14A), proxy filed April 4, 2024 |
| Vanguard Group | 2,792,208 | 9.79% | Form 13F, quarter ended March 31, 2024 |
| Avoro Capital Advisors LLC | 2,565,555 | 8.99% | Proxy statement (DEF 14A), proxy filed April 4, 2024 |
| Krish S. Krishnan | 1,835,662 | 6.43% | Proxy statement (DEF 14A), proxy filed April 4, 2024 |
| Suma M. Krishnan | 1,755,332 | 6.15% | Proxy statement (DEF 14A), proxy filed April 4, 2024 |
| Redmile Group, LLC | 1,733,189 | 6.08% | Proxy statement (DEF 14A), proxy filed April 4, 2024 |
| State Street | 944,547 | 3.31% | Form 13F, quarter ended March 31, 2024 |
| T. Rowe Price | 658,618 | 2.31% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 28,528,000 shares outstanding, as reported by KRYSTAL BIOTECH INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At KRYSTAL BIOTECH INC.'s shareholder meeting held May 17, 2024, in the 2023-2024 proxy season, 256 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,751 separate fund positions. On the most widely held item on that ballot — APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, ON A NON-BINDING… — KRYSTAL BIOTECH INC.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: KRYSTAL BIOTECH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KRYSTAL BIOTECH INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
KRYSTAL BIOTECH INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “KRYSTAL BIOTECH (KRYS) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/krystal-biotech-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.